UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033417
Receipt number R000038102
Scientific Title Study on postprandial blood glucose level of sugar based polyol.
Date of disclosure of the study information 2018/07/17
Last modified on 2018/09/11 10:22:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on postprandial blood glucose level of sugar based polyol.

Acronym

Study on postprandial blood glucose level of sugar based polyol.

Scientific Title

Study on postprandial blood glucose level of sugar based polyol.

Scientific Title:Acronym

Study on postprandial blood glucose level of sugar based polyol.

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Test on postprandial blood glucose level of sugar based polyol

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood glucose level(deltaAUC,deltaCmax,deltaC,Tmax)

Key secondary outcomes

none


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingest total 25.3 g of date syrup

Interventions/Control_2

Ingest total 26.0 g of maltitol mixed date syrup

Interventions/Control_3

Ingest total 20.2 g of glucose

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Persons who have a UAE nationality in their twenties
3. Persons whose BMI is 30.0 or less
4. Persons who do not have impaired glucose tolerance in the past one year examination
5. Persons who are not taking drugs such as anti-hypertensive agents

Key exclusion criteria

1. Persons who have a chronic disease and is under medication, or has a serious disease history
2. Persons who are allergic to the test food
3. Persons who participated in other examination during the first month before the start of the exam, or those who plan to participate in other exams following this exam agreement
4. Persons who are breastfeeding, pregnant, scheduled or hoping to be pregnant during the exam period
5. Persons who are judged inappropriate for the exam by the principal investigator

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takamasa Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Research and Development

Zip code


Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

masudat@hc-sys.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takamasa Masuda

Organization

Healthcare Systems Co., Ltd.

Division name

Research and Development

Zip code


Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

masudat@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

B food science Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 07 Month 13 Day

Date of IRB


Anticipated trial start date

2018 Year 07 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 07 Month 17 Day

Last modified on

2018 Year 09 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038102


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name